Diabetes

Sparrow flying from a tree branch
Biotech

Sparrow flits forward with $95M for midstage diabetes asset

The Oregon biotech will use the raise for a phase 2b trial of oral small molecule clofutriben in patients with Type 2 diabetes and excess cortisol.
Darren Incorvaia Sep 24, 2025 11:22am
doctor walking away in hospital hallway

Glooko buys Monarch’s EndoTool to enter in-patient diabetes care

Sep 23, 2025 7:30am
board room

Dexcom CEO goes on leave while Insulet taps new CFO

Sep 17, 2025 12:15pm
Doustdar
Favicon Fierce Pharma

Novo charts major restructuring, layoffs under new CEO

Sep 10, 2025 8:41am
Senseonics Eversense 365 placed on arm

Senseonics to retake Eversense commercial control from Ascensia

Sep 5, 2025 2:00pm
Medtronic Simplera Sync MiniMed 780G meal

Medtronic debuts Abbott Instinct CGM as MiniMed 780G enters T2D

Sep 2, 2025 11:00am